CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $562.04M, above the global median of $520.53M
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.14BUSDvs all stocks (USD)
Revenue (TTM)
562.04MUSDvs all stocks (USD)
Profit Margin
-14.36%Beta
0.1920xvs all stocks
52-Week Change
-60.02%vs all stocks
Market Capitalization
1.14BUSDvs all stocks (USD)
Enterprise Value
2.45BUSDvs all stocks (USD)
Forward P/E
14.40xPrice to Sales (TTM)
2.03xEnterprise to Revenue
4.36xEnterprise to EBITDA
23.49xGross Margin
56.47%Profit Margin
-14.36%Operating Margin
9.13%Return on Assets (TTM)
3.84%Revenue (TTM)
562.04MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.92USDUpdated Jul 17, 2026Quarterly Revenue Growth
-20.20%Gross Profit (TTM)
345.84MUSDvs all stocks (USD)
EBITDA (TTM)
109.61MUSDvs all stocks (USD)
Net Income (TTM)
-80.73MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-99.10%Operating Cash Flow (TTM)
-123.17MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-92.55MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 17, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
586.32MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
235.56MUSDFY2025 · Dec 31, 2025Gross Profit
350.76MUSDFY2025 · Dec 31, 2025Operating Income
78.21MUSDvs all stocks (USD)
Pre-tax Income
136.35MUSDFY2025 · Dec 31, 2025Income Tax Expense
108.43MUSDFY2025 · Dec 31, 2025Net Income
27.92MUSDFY2025 · Dec 31, 2025EBIT
273.22MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
109.61MUSDFY2025 · Dec 31, 2025Research & Development
184.19MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
84.92MUSDFY2025 · Dec 31, 2025Other Operating Expenses
-2.58MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
2.77MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
136.87MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.1000USDFY2025 · Dec 31, 2025EPS (Diluted)
0.1000USDFY2025 · Dec 31, 2025Basic Shares Outstanding
279.19MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
279.19MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
27.92MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-48.38MUSDFY2025 · Dec 31, 2025Free Cash Flow
-112.85MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
172.36MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
27.92MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
37.85MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
108.43MUSDFY2025 · Dec 31, 2025Stock-based Compensation
7.38MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-67.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-2.08MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-160.87MUSDFY2025 · Dec 31, 2025Capital Expenditures
-64.47MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-31.66MUSDFY2025 · Dec 31, 2025Net Acquisitions
-8.09MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-72.56MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
233.48MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-35.79MUSDFY2025 · Dec 31, 2025Other Financing Charges
-9.34MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
270.83MUSDFY2025 · Dec 31, 2025Shares Outstanding
312.15MSharesUpdated Jul 17, 2026Float Shares
123.17MSharesUpdated Jul 17, 2026Shares Short
2.92MSharesUpdated Jul 17, 2026Short Ratio
2.46daysvs all stocks
Short % of Shares Outstanding
2.06%vs all stocks
% Held by Insiders
54.54%vs all stocks
% Held by Institutions
5.12%vs all stocks
Total Cash (MRQ)
63.83MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.2040USDUpdated Jul 17, 2026Total Debt (MRQ)
1.46BUSDvs all stocks (USD)
Current Ratio (MRQ)
1.75xBook Value per Share (MRQ)
-0.9040USDUpdated Jul 17, 2026Total Assets
1.49BUSDvs all stocks (USD)
Total Current Assets
574.01MUSDFY2025 · Dec 31, 2025Total Liabilities
1.77BUSDFY2025 · Dec 31, 2025Total Non-current Assets
913.08MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.47BUSDFY2025 · Dec 31, 2025Total Current Liabilities
304.08MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
172.36MUSDFY2025 · Dec 31, 2025Accounts Receivable
69.74MUSDFY2025 · Dec 31, 2025Inventory
220.05MUSDFY2025 · Dec 31, 2025Accounts Payable
126.12MUSDFY2025 · Dec 31, 2025Short-term Debt
49.00MUSDFY2025 · Dec 31, 2025Deferred Revenue
30.36MUSDFY2025 · Dec 31, 2025Long-term Debt
1.40BUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.93MUSDFY2025 · Dec 31, 2025Retained Earnings
-2.41BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
-284.49MUSDvs all stocks (USD)
52-Week Low
2.94USDUpdated Jul 17, 202652-Week High
9.94USDUpdated Jul 17, 202652-Week Change
-60.02%vs all stocks
Beta
0.1920xvs all stocks
50-Day MA
3.56USDUpdated Jul 17, 2026200-Day MA
4.77USDUpdated Jul 17, 2026Avg 10-Day Volume
579.04KSharesUpdated Jul 17, 2026Avg 30-Day Volume
998.89KSharesUpdated Jul 17, 2026Diluted EPS (TTM)
-0.3000USDUpdated Jul 17, 2026Other Income / Expense
201.45MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.56Profit Margin: -0.14
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $562.04M, above the global median of $520.53MNotable
Revenue (USD): 562,043,008Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
SSY Group Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Gen Ilac ve Saglik Urunleri A.S.
Tier 1ProductionApproval-Gated PipelineRule
Innovita Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sino Medical Sciences Technology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Savara Inc.
Tier 1ProductionApproval-Gated PipelineRule
MeiraGTx Holdings plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shantou Institute of Ultrasonic Instruments Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Capricor Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eton Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shandong Longda Meishi Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated